Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease

Author:

Bateman Randall J.1,Smith Janice1,Donohue Michael C.1,Delmar Paul1,Abbas Rachid1ORCID,Salloway Stephen1,Wojtowicz Jakub1,Blennow Kaj1,Bittner Tobias1,Black Sandra E.1,Klein Gregory1,Boada Mercè1,Grimmer Timo1,Tamaoka Akira1,Perry Richard J.1,Turner R. Scott1,Watson David1,Woodward Michael1,Thanasopoulou Angeliki1,Lane Christopher1,Baudler Monika1,Fox Nick C.1,Cummings Jeffrey L.1,Fontoura Paulo1,Doody Rachelle S.1

Affiliation:

1. From the Department of Neurology, Washington University School of Medicine, St. Louis (R.J.B.); Roche Products, Welwyn Garden City (J.S., C.L.), and the Department of Brain Sciences, Faculty of Medicine, Imperial College London (R.J.P.), and the Dementia Research Centre, Department of Neurodegenerative Disease, and the U.K. Dementia Research Institute, Queen Square Institute of Neurology, University College London (N.C.F.), London — all in the United Kingdom; the Alzheimer’s Therapeutic Research...

Funder

F. Hoffmann-La Roche

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3